BILLERICA, Mass.--(BUSINESS WIRE)--July 17, 2006--Millipore Corporation (NYSE: MIL - News) announced today that it has completed its acquisition of Serologicals following approval by Serologicals’ shareholders last week. The acquisition will transform Millipore into a life science industry leader with combined annual revenues of approximately $1.4 billion, based on 2006 full year projections.
